Compensatory signals associated with the activation of human GC 5′ splice sites

Nucleic Acids Research

Volumn 39, Issue 16, 2011, Pages 7077-7091

  Kralovicova, Jana ^a   Hwang, Gyulin ^a   Asplund, A Charlotta ^b   Churbanov, Alexander ^c   Smith, C I Edvard ^b   Vorechovsky, Igor ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c NEW MEXICO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE ARGININE RICH PROTEIN;

5' UNTRANSLATED REGION; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DNA FLANKING REGION; ENHANCER REGION; GENE ACTIVATION; GENE LOCATION; GENE MUTATION; GENE SWITCHING; GENETIC SELECTION; HUMAN; HUMAN CELL; INTRON; MUTATIONAL ANALYSIS; NUCLEOTIDE REPEAT; POINT MUTATION; PRIORITY JOURNAL; RNA SPLICING; RNA STRUCTURE; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SILENCER ELEMENT; TRANSCRIPTION INITIATION; VALIDATION PROCESS; X LINKED AGAMMAGLOBULINEMIA;

AGAMMAGLOBULINEMIA; CELL LINE; GENETIC DISEASES, X-LINKED; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; INTRONS; OLIGONUCLEOTIDES, ANTISENSE; POINT MUTATION; PROTEIN-TYROSINE KINASES; REGULATORY SEQUENCES, RIBONUCLEIC ACID; RNA SPLICE SITES; RNA SPLICING;

EID: 80052466712     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr306     Document Type: Article

References (104)

1. Wahl, M.C., Will, C.L. and Lü hrmann, R. (2009) The spliceosome: design principles of a dynamic RNP machine. Cell, 136, 701-718.
2. Burge, C.B., Tuschl, T. and Sharp, P.A. (1999) In Gesteland, R.F., Cech, T.R. and Atkins, J.F. (eds), The RNA World. Cold Spring Harbor Laboratory Press, New York, pp. 525-560.
3. Buratti, E., Muro, A.F., Giombi, M., Gherbassi, D., Iaconcig, A. and Baralle, F.E. (2004) RNA folding affects the recruitment of SR proteins by mouse and human polypurinic enhancer elements in the fibronectin EDA exon. Mol. Cell. Biol., 24, 1387-1400. (Pubitemid 38112198)
4. Warf, M.B. and Berglund, J.A. (2010) Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem. Sci., 35, 169-178.
5. Zhang, X.H. and Chasin, L.A. (2006) Comparison of multiple vertebrate genomes reveals the birth and evolution of human exons. Proc. Natl Acad. Sci. USA, 103, 13427-13432. (Pubitemid 44380124)
6. Kralovicova, J. and Vorechovsky, I. (2010) Allele-dependent recognition of the 30 splice site of INS intron 1. Hum. Genet., 128, 383-400.
7. Zhuang, Y. and Weiner, A.M. (1986) A compensatory base change in U1 snRNA suppresses a 50 splice site mutation. Cell, 46, 827-835. (Pubitemid 16027931)
8. Bruzik, J.P. and Steitz, J.A. (1990) Spliced leader RNA sequences can substitute for the essential 50 end of U1 RNA during splicing in a mammalian in vitro system. Cell, 62, 889-899.
9. Crispino, J.D., Blencowe, B.J. and Sharp, P.A. (1994) Complementation by SR proteins of pre-mRNA splicing reactions depleted of U1 snRNP. Science, 265, 1866-1869. (Pubitemid 24324242)
10. Zhong, X.-Y., Wang, P., Han, J., Rosenfeld, M.G. and Fu, X.-D. (2009) SR proteins in vertical integration of gene expresion from transcription to RNA processing to translation. Mol. Cell, 35, 1-10.
11. Moore, M.J. and Proudfoot, N.J. (2009) Pre-mRNA processing reaches back to transcription and ahead to translation. Cell, 136, 688-700.
12. Thanaraj, T.A. and Clark, F. (2001) Human GC-AG alternative intron isoforms with weak donor sites show enhanced consensus at acceptor exon positions. Nucleic Acids Res., 29, 2581-2593. (Pubitemid 32600315)
13. Burset, M., Seledtsov, I.A. and Solovyev, V.V. (2000) Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res., 28, 4364-4375.
14. Sheth, N., Roca, X., Hastings, M.L., Roeder, T., Krainer, A.R. and Sachidanandam, R. (2006) Comprehensive splice-site analysis using comparative genomics. Nucleic Acids Res., 34, 3955-3967. (Pubitemid 44391011)
15. Churbanov, A., Winters-Hilt, S., Koonin, E.V. and Rogozin, I.B. (2008) Accumulation of GC donor splice signals in mammals. Biol. Direct, 3, 30.
16. Buratti, E., Chivers, M.C., Kralovicova, J., Romano, M., Baralle, M., Krainer, A.R. and Vorechovsky, I. (2007) Aberrant 50 splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res., 35, 4250-4263. (Pubitemid 47260233)
17. Dou, Y., Fox-Walsh, K.L., Baldi, P.F. and Hertel, K.J. (2006) Genomic splice-site analysis reveals frequent alternative splicing close to the dominant splice site. RNA, 12, 2047-2056. (Pubitemid 44865952)
18. Jackson, I.J. (1991) A reappraisal of non-consensus mRNA splice sites. Nucleic Acids Res., 19, 3795-3798. (Pubitemid 21912743)
19. Mount, S.M. (2000) Genomic sequence, splicing, and gene annotation. Am. J. Hum. Genet., 67, 788-792.
20. Kitamura-Abe, S., Itoh, H., Washio, T., Tsutsumi, A. and Tomita, M. (2004) Characterization of the splice sites in GT-AG and GC-AG introns in higher eukaryotes using full-length cDNAs. J. Bioinform. Comput. Biol., 2, 309-331. (Pubitemid 39089020)
21. Burset, M., Seledtsov, I.A. and Solovyev, V.V. (2001) SpliceDB: database of canonical and non-canonical mammalian splice sites. Nucleic Acids Res., 29, 255-259. (Pubitemid 32054461)
22. Abril, J.F., Castelo, R. and Guigo, R. (2005) Comparison of splice sites in mammals and chicken. Genome Res., 15, 111-119.
23. Aebi, M., Hornig, H. and Weissmann, C. (1987) 50 cleavage site in eukaryotic pre-mRNA splicing is determined by the overall 50 splice region, not by the conserved 50 GU. Cell, 50, 237-246.
24. Vetrie, D., Vorechovsky, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarströ m, L., Kinnon, C., Levinsky, R., Bobrow, M. et al. (1993) The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature, 361, 226-233. (Pubitemid 23034471)
25. Kralovicova, J. and Vorechovsky, I. (2007) Global control of aberrant splice site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition. Nucleic Acids Res., 35, 6399-6413. (Pubitemid 350119565)
26. Kralovicova, J., Houngninou-Molango, S., Krä mer, A. and Vorechovsky, I. (2004) Branch sites haplotypes that control alternative splicing. Hum. Mol. Genet., 13, 3189-3202. (Pubitemid 40045271)
27. Deirdre, A., Scadden, J. and Smith, C.W. (1995) Interactions between the terminal bases of mammalian introns are retained in inosine-containing pre-mRNAs. EMBO J., 14, 3236-3246.
28. Heinonen, J.E., Smith, C.I. and Nore, B.F. (2002) Silencing of Bruton0s tyrosine kinase (Btk) using short interfering RNA duplexes (siRNA). FEBS Lett., 527, 274-278. (Pubitemid 35253878)
29. Kashima, T. and Manley, J.L. (2003) A negative element in SMN2 exon 7 inhibits splicing in spinal muscular atrophy. Nat. Genet., 34, 460-463. (Pubitemid 36935342)
30. Lei, H. and Vorechovsky, I. (2005) Identification of splicing silencers and enhancers in sense Alus: a role for pseudo-acceptors in splice site repression. Mol. Cell. Biol., 25, 6912-6920. (Pubitemid 41105892)
31. Reuter, J.S. and Mathews, D.H. (2010) RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics, 11, 129.
32. Kralovicova, J., Christensen, M.B. and Vorechovsky, I. (2005) Biased exon/intron distribution of cryptic and de novo 30 splice sites. Nucleic Acids Res., 33, 4882-4898. (Pubitemid 41418888)
33. Buratti, E., Chivers, M.C., Hwang, G. and Vorechovsky, I. (2011) DBASS3 and DBASS5: databases of aberrant 30 and 50 splice sites in human disease genes. Nucleic Acids Res., 39, D86-D91.
34. Jones, C.T., McIntosh, I., Keston, M., Ferguson, A. and Brock, D.J. (1992) Three novel mutations in the cystic fibrosis gene detected by chemical cleavage: analysis of variant splicing and a nonsense mutation. Hum. Mol. Genet., 1, 11-17.
35. Sakamoto, O., Ohura, T., Katsushima, Y., Fujiwara, I., Ogawa, E., Miyabayashi, S. and Iinuma, K. (2001) A novel intronic mutation of the TAZ (G4.5) gene in a patient with Barth syndrome: creation of a 50 splice donor site with variant GC consensus and elongation of the upstream exon. Hum. Genet., 109, 559-563. (Pubitemid 33089316)
36. Pagani, F., Buratti, E., Stuani, C., Bendix, R., Dork, T. and Baralle, F.E. (2002) A new type of mutation causes a splicing defect in ATM. Nat. Genet., 30, 426-429.
37. Pros, E., Gomez, C., Martin, T., Fabregas, P., Serra, E. and Lazaro, C. (2008) Nature and mRNA effect of 282 different NF1 point mutations: focus on splicing alterations. Hum. Mutat., 29, E173-E193.
38. Kossack, N., Simoni, M., Richter-Unruh, A., Themmen, A.P. and Gromoll, J. (2008) Mutations in a novel, cryptic exon of the luteinizing hormone/chorionic gonadotropin receptor gene cause male pseudohermaphroditism. PLoS Med., 5, e88.
39. Yeo, G. and Burge, C.B. (2004) Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J. Comput. Biol., 11, 377-394. (Pubitemid 38901668)
40. Yeakley, J.M., Morfin, J.P., Rosenfeld, M.G. and Fu, X.D. (1996) A complex of nuclear proteins mediates SR protein binding to a purine-rich splicing enhancer. Proc. Natl Acad. Sci. USA, 93, 7582-7587.
41. Coulter, L.R., Landree, M.A. and Cooper, T.A. (1997) Identification of a new class of exonic splicing enhancers by in vivo selection. Mol. Cell. Biol., 17, 2143-2150. (Pubitemid 27133300)
42. Vorechovsky, I. (2010) Transposable elements in disease-associated cryptic exons. Hum. Genet., 127, 135-154.
43. Hiller, M., Zhang, Z., Backofen, R. and Stamm, S. (2007) Pre-mRNA secondary structures influence exon recognition. PLoS Genet., 3, e204.
44. Zhang, X.H. and Chasin, L.A. (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev., 18, 1241-1250. (Pubitemid 38720592)
45. Zhang, C., Li, W.H., Krainer, A.R. and Zhang, M.Q. (2008) RNA landscape of evolution for optimal exon and intron discrimination. Proc. Natl Acad. Sci. USA, 105, 5797-5802. (Pubitemid 351758452)
46. Wang, Z., Rolish, M.E., Yeo, G., Tung, V., Mawson, M. and Burge, C.B. (2004) Systematic identification and analysis of exonic splicing silencers. Cell, 119, 831-845. (Pubitemid 40017689)
47. Krainer, A.R., Conway, G.C. and Kozak, D. (1990) The essential pre-mRNA splicing factor SF2 influences 50 splice site selection by activating proximal sites. Cell, 62, 35-42.
48. Eperon, I.C., Ireland, D.C., Smith, R.A., Mayeda, A. and Krainer, A.R. (1993) Pathways for selection of 50 splice sites by U1 snRNPs and SF2/ASF. EMBO J., 12, 3607-3617. (Pubitemid 23256447)
49. Gutell, R.R., Cannone, J.J., Shang, Z., Du, Y. and Serra, M.J. (2000) A story: unpaired adenosine bases in ribosomal RNAs. J. Mol. Biol., 304, 335-354.
50. Nissen, P., Ippolito, J.A., Ban, N., Moore, P.B. and Steitz, T.A. (2001) RNA tertiary interactions in the large ribosomal subunit: the A-minor motif. Proc. Natl Acad. Sci. USA, 98, 4899-4903. (Pubitemid 32397054)
51. Schwartz, S., Gal-Mark, N., Kfir, N., Oren, R., Kim, E. and Ast, G. (2009) Alu exonization events reveal features required for precise recognition of exons by the splicing machinery. PLoS Comput. Biol., 5, e1000300.
52. Lev-Maor, G., Ram, O., Kim, E., Sela, N., Goren, A., Levanon, E.Y. and Ast, G. (2008) Intronic Alus influence alternative splicing. PLoS Genet., 4, e1000204.
53. Sorek, R., Lev-Maor, G., Reznik, M., Dagan, T., Belinky, F., Graur, D. and Ast, G. (2004) Minimal conditions for exonization of intronic sequences: 50 splice site formation in Alu exons. Mol. Cell, 14, 221-231. (Pubitemid 38515649)
54. Lev-Maor, G., Sorek, R., Shomron, N. and Ast, G. (2003) The birth of an alternatively spliced exon: 30 splice-site selection in Alu exons. Science, 300, 1288-1291. (Pubitemid 36618239)
55. Ast, G. (2004) How did alternative splicing evolve? Nat Rev. Genet., 5, 773-782. (Pubitemid 39336361)
56. Iwata, H. and Gotoh, O. (2011) Comparative analysis of information contents relevant to recognition of introns in many species. BMC Genomics, 12, 45.
57. Palaniswamy, R., Teglund, S., Lauth, M., Zaphiropoulos, P.G. and Shimokawa, T. (2010) Genetic variations regulate alternative splicing in the 50 untranslated regions of the mouse glioma-associated oncogene 1, Gli1. BMC Mol Biol., 11, 32.
58. Tsai, K.W., Tseng, H.C. and Lin, W.C. (2008) Two wobble-splicing events affect ING4 protein subnuclear localization and degradation. Exp. Cell Res., 314, 3130-3141.
59. Flomen, R., Knight, J., Sham, P., Kerwin, R. and Makoff, A. (2004) Evidence that RNA editing modulates splice site selection in the 5-HT2C receptor gene. Nucleic Acids Res., 32, 2113-2122. (Pubitemid 38864685)
60. Rueter, S.M., Dawson, T.R. and Emeson, R.B. (1999) Regulation of alternative splicing by RNA editing. Nature, 399, 75-80.
61. Lev-Maor, G., Sorek, R., Levanon, E.Y., Paz, N., Eisenberg, E. and Ast, G. (2007) RNA-editing-mediated exon evolution. Genome Biol., 8, R29.
62. Kiran, A. and Baranov, P.V. (2010) DARNED: a DAtabase of RNa EDiting in humans. Bioinformatics, 26, 1772-1776.
63. Fisher, C.W., Fisher, C.R., Chuang, J.L., Lau, K.S., Chuang, D.T. and Cox, R.P. (1993) Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations. Am. J. Hum. Genet., 52, 414-424. (Pubitemid 23072425)
64. Schwarze, U., Starman, B.J. and Byers, P.H. (1999) Redefinition of exon 7 in the COL1A1 gene of type I collagen by an intron 8 splice-donor-site mutation in a form of osteogenesis imperfecta: influence of intron splice order on outcome of splice-site mutation. Am. J. Hum. Genet., 65, 336-344. (Pubitemid 30462991)
65. Hicks, M.J., Mueller, W.F., Shepard, P.J. and Hertel, K.J. (2010) Competing upstream 50 splice sites enhance the rate of proximal splicing. Mol. Cell. Biol., 30, 1878-1886.
66. Nemeroff, M.E., Utans, U., Kramer, A. and Krug, R.M. (1992) Identification of cis-acting intron and exon regions in influenza virus NS1 mRNA that inhibit splicing and cause the formation of aberrantly sedimenting presplicing complexes. Mol. Cell. Biol., 12, 962-970.
67. Alvarez, C.J. and Wise, J.A. (2001) Activation of a cryptic 50 splice site by U1 snRNA. RNA, 7, 342-350. (Pubitemid 32381910)
68. Feldhahn, N., Rio, P., Soh, B.N., Liedtke, S., Sprangers, M., Klein, F., Wernet, P., Jumaa, H., Hofmann, W.K., Hanenberg, H. et al. (2005) Deficiency of Bruton0s tyrosine kinase in B cell precursor leukemia cells. Proc. Natl Acad. Sci. USA, 102, 13266-13271. (Pubitemid 41325012)
69. Raponi, M., Kralovicova, J., Copson, E., Divina, P., Eccles, D., Johnson, P.M., Baralle, D. and Vorechovsky, I. (2011) Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 5. Hum. Mutat., 32, 436-444.
70. Churbanov, A., Vorechovsky, I. and Hicks, C. (2010) A method of predicting changes in human gene splicing induced by genetic variants in context of cis-acting elements. BMC Bioinformatics, 11, 22.
71. Ramchatesingh, J., Zahler, A.M., Neugebauer, K.M., Roth, M.B. and Cooper, T.A. (1995) A subset of SR proteins activates splicing of the cardiac troponin T alternative exon by direct interactions with an exonic enhancer. Mol. Cell. Biol., 15, 4898-4907.
72. Lynch, K.W. and Maniatis, T. (1996) Assembly of specific SR protein complexes on distinct regulatory elements of the Drosophila doublesex splicing enhancer. Genes Dev., 10, 2089-2101. (Pubitemid 26346116)
73. Tacke, R., Tohyama, M., Ogawa, S. and Manley, J.L. (1998) Human Tra2 proteins are sequence-specific activators of pre-mRNA splicing. Cell, 93, 139-148. (Pubitemid 28173559)
74. Nasim, M.T., Chernova, T.K., Chowdhury, H.M., Yue, B.G. and Eperon, I.C. (2003) HnRNP G and Tra2beta: opposite effects on splicing matched by antagonism in RNA binding. Hum. Mol. Genet., 12, 1337-1348. (Pubitemid 36722614)
75. Hofmann, Y., Lorson, C.L., Stamm, S., Androphy, E.J. and Wirth, B. (2000) Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2). Proc. Natl Acad. Sci. USA, 97, 9618-9623. (Pubitemid 30650825)
76. Tsuda, K., Someya, T., Kuwasako, K., Takahashi, M., He, F., Unzai, S., Inoue, M., Harada, T., Watanabe, S., Terada, T. et al. (2010) Structural basis for the dual RNA-recognition modes of human Tra2-{beta} RRM. Nucleic Acids Res., 39, 1538-1553.
77. Clery, A., Jayne, S., Benderska, N., Dominguez, C., Stamm, S. and Allain, F.H. (2011) Molecular basis of purine-rich RNA recognition by the human SR-like protein Tra2-beta1. Nat. Struct. Mol. Biol., 18, 443-450.
78. Giot, L., Bader, J.S., Brouwer, C., Chaudhuri, A., Kuang, B., Li, Y., Hao, Y.L., Ooi, C.E., Godwin, B., Vitols, E. et al. (2003) A protein interaction map of Drosophila melanogaster. Science, 302, 1727-1736. (Pubitemid 37505730)
79. Doherty, E.A., Batey, R.T., Masquida, B. and Doudna, J.A. (2001) A universal mode of helix packing in RNA. Nat. Struct. Biol., 8, 339-343. (Pubitemid 32275020)
80. McCullough, A.J. and Berget, S.M. (1997) G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol. Cell. Biol., 17, 4562-4571. (Pubitemid 27318133)
81. Kanopka, A., Muhlemann, O. and Akusjarvi, G. (1996) Inhibition by SR proteins of splicing of a regulated adenovirus pre-mRNA. Nature, 381, 535-538. (Pubitemid 26170934)
82. Stoilov, P., Daoud, R., Nayler, O. and Stamm, S. (2004) Human tra2-beta1 autoregulates its protein concentration by influencing alternative splicing of its pre-mRNA. Hum. Mol. Genet., 13, 509-524. (Pubitemid 38313210)
83. Buratti, E., Stuani, C., De Prato, G. and Baralle, F.E. (2007) SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer. Nucleic Acids Res., 35, 4359-4368. (Pubitemid 47244589)
84. Makalowski, W., Mitchell, G.A. and Labuda, D. (1994) Alu sequences in the coding regions of mRNA: a source of protein variability. Trends Genet., 10, 188-193. (Pubitemid 24162752)
85. Lei, H., Day, I.N.M. and Vorechovsky, I. (2005) Exonization of AluYa5 in the human ACE gene requires mutations in both 30 and 50 splice sites and is facilitated by a conserved splicing enhancer. Nucleic Acids Res., 33, 3897-3906. (Pubitemid 41418558)
86. Vorechovsky, I. (2006) Aberrant 30 splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization. Nucleic Acids Res., 34, 4630-4641. (Pubitemid 44590994)
87. Fairbrother, W.G., Yeh, R.F., Sharp, P.A. and Burge, C.B. (2002) Predictive identification of exonic splicing enhancers in human genes. Science, 297, 1007-1013. (Pubitemid 34856033)
88. Fairbrother, W.G., Yeo, G.W., Yeh, R., Goldstein, P., Mawson, M., Sharp, P.A. and Burge, C.B. (2004) RESCUE-ESE identifies candidate exonic splicing enhancers in vertebrate exons. Nucleic Acids Res., 32, W187-W190. (Pubitemid 38997326)
89. Cartegni, L., Wang, J., Zhu, Z., Zhang, M.Q. and Krainer, A.R. (2003) ESEfinder: a web resource to identify exonic splicing enhancers. Nucleic Acids Res., 31, 3568-3571. (Pubitemid 37442199)
90. Smith, P.J., Zhang, C., Wang, J., Chew, S.L., Zhang, M.Q. and Krainer, A.R. (2006) An increased specificity score matrix for the prediction of SF2/ASF-specific exonic splicing enhancers. Hum. Mol. Genet., 15, 2490-2508. (Pubitemid 44288702)
91. Wollerton, M.C., Gooding, C., Wagner, E.J., Garcia-Blanco, M.A. and Smith, C.W. (2004) Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Mol. Cell, 13, 91-100. (Pubitemid 38117118)
92. Spellman, R., Llorian, M. and Smith, C.W. (2007) Crossregulation and functional redundancy between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol. Cell, 27, 420-434. (Pubitemid 47126939)
93. Lander, E.S., Linton, L.M., Birren, B., Nusbaum, C., Zody, M.C., Baldwin, J., Devon, K., Dewar, K., Doyle, M., FitzHugh, W. et al. (2001) Initial sequencing and analysis of the human genome. Nature, 409, 860-921. (Pubitemid 32165345)
94. Steijlen, P.M., van Steensel, M.A., Jansen, B.J., Blokx, W., van de Kerkhof, P.C., Happle, R. and van Geel, M. (2004) Cryptic splicing at a non-consensus splice-donor in a patient with a novel mutation in the plakophilin-1 gene. J. Invest. Dermatol., 122, 1321-1324. (Pubitemid 38651109)
95. Spena, S., Duga, S., Asselta, R., Malcovati, M., Peyvandi, F. and Tenchini, M.L. (2002) Congenital afibrinogenemia: first identification of splicing mutations in the fibrinogen Bbeta-chain gene causing activation of cryptic splice sites. Blood, 100, 4478-4484. (Pubitemid 35429688)
96. Harland, M., Taylor, C.F., Chambers, P.A., Kukalizch, K., Randerson-Moor, J.A., Gruis, N.A., de Snoo, F.A., ter Huurne, J.A., Goldstein, A.M., Tucker, M.A. et al. (2005) A mutation hotspot at the p14ARF splice site. Oncogene, 24, 4604-4608. (Pubitemid 41032625)
97. Tanioka, M., Budiyant, A., Ueda, T., Nagano, T., Ichihashi, M., Miyachi, Y. and Nishigori, C. (2005) A novel XPA gene mutation and its functional analysis in a Japanese patient with xeroderma pigmentosum group A. J. Invest. Dermatol., 125, 244-246. (Pubitemid 41648156)
98. Urban, Z., Michels, V.V., Thibodeau, S.N., Donis-Keller, H., Csiszar, K. and Boyd, C.D. (1999) Supravalvular aortic stenosis: a splice site mutation within the elastin gene results in reduced expression of two aberrantly spliced transcripts. Hum. Genet., 104, 135-142. (Pubitemid 29123605)
99. Goyette, P., Frosst, P., Rosenblatt, D.S. and Rozen, R. (1995) Seven novel mutations in the methylenetetrahydrofolate reductase gene and genotype/phenotype correlations in severe methylenetetrahydrofolate reductase deficiency. Am. J. Hum. Genet., 56, 1052-1059.
100. Wimmer, K., Roca, X., Beiglbock, H., Callens, T., Etzler, J., Rao, A.R., Krainer, A.R., Fonatsch, C. and Messiaen, L. (2007) Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 50 splice-site disruption. Hum. Mutat., 28, 599-612. (Pubitemid 46744290)
101. Hong, K., Guerchicoff, A., Pollevick, G.D., Oliva, A., Dumaine, R., de Zutter, M., Burashnikov, E., Wu, Y.S., Brugada, J., Brugada, P. et al. (2005) Cryptic 50 splice site activation in SCN5A associated with Brugada syndrome. J. Mol. Cell. Cardiol., 38, 555-560. (Pubitemid 40461819)
102. Ars, E., Serra, E., Garcia, J., Kruyer, H., Gaona, A., Lazaro, C. and Estivill, X. (2000) Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1. Hum. Mol. Genet., 9, 237-247. (Pubitemid 30052747)
103. Roca, X., Sachidanandam, R. and Krainer, A.R. (2005) Determinants of the inherent strength of human 50 splice sites. RNA, 11, 683-698. (Pubitemid 40594335)
104. Divina, P., Kvitkovicova, A. and Vorechovsky, I. (2009) Ab initio prediction of cryptic splice-site activation and exon skipping. Eur. J. Hum. Genet., 17, 759-765.